(VIANEWS) – Yesterday, the Innrs artificial intelligence algorithm suggested a few financial assets that would make investors a profit today.
Via News is daily fact-checking an AI algorithm that aims to predict financial assets’ next session’s price and next week’s trend.
Innrs provides AI-based statistical tools to help investors make decisions.
If you had invested in last session’s Innrs AI prediction, you would have a ROI of 0.01%.
| Financial Asset | Accuracy | Prediction | ROI |
|---|---|---|---|
| MercadoLibre (MELI) | 93.3% | $1592.6 | 4.05% ✅ |
| Royal Caribbean Cruises (RCL) | 93.39% | $107.57 | 2.23% ✅ |
| Baxter International (BAX) | 98.62% | $37.05 | 1.11% ✅ |
| Quidel (QDEL) | 93.02% | $70.55 | 0.52% ✅ |
| Ingersoll (IR) | 99.6% | $71.05 | 0.52% ✅ |
| IDEXX Laboratories (IDXX) | 92.99% | $490.89 | 0.49% ✅ |
| Medtronic (MDT) | 93.58% | $80.16 | 0.42% ✅ |
| Smith & Nephew (SNN) | 93.97% | $26.07 | 0.19% ✅ |
| Insulet (PODD) | 94.09% | $191.84 | 0.19% ✅ |
| Coca-Cola (KO) | 97.2% | $60.1 | 0.03% ✅ |
| PennyMac (PFSI) | 93.25% | $78.06 | -0.04% |
| Abbott Laboratories (ABT) | 98.74% | $106.3 | -0.05% |
| American Express (AXP) | 93.2% | $169.54 | -0.09% |
| Verizon (VZ) | 94.01% | $37.81 | -0.11% |
| AT&T (T) | 99.55% | $16.31 | -0.12% |
| Netflix (NFLX) | 97.2% | $494.98 | -0.13% |
| Ares Capital (ARCC) | 93.36% | $20.3 | -0.2% |
| Sysco Corporation (SYY) | 97.79% | $74.67 | -0.25% |
| T-Mobile (TMUS) | 93.55% | $152.51 | -0.3% |
| Coca-Cola Consolidated (COKE) | 98.76% | $748.88 | -0.47% |
| Teleflex (TFX) | 93.49% | $226.79 | -0.47% |
| Marriott International (MAR) | 93.64% | $215.56 | -0.72% |
| Johnson & Johnson (JNJ) | 97.5% | $156.36 | -0.73% |
| Intuitive Surgical (ISRG) | 98.93% | $326.72 | -0.75% |
| Charles River Laboratories (CRL) | 98.06% | $201.6 | -0.78% |
| Zoetis (ZTS) | 94.11% | $184.03 | -0.81% |
| Walt Disney (DIS) | 93.51% | $99.42 | -0.84% |
| Public Service Enterprise Group (PEG) | 98.31% | $66.38 | -1.03% |
| Humana (HUM) | 92.74% | $532.74 | -1.43% |
1. MercadoLibre (MELI)
MercadoLibre has been having an accuracy rate of 93.3% over the last 10 sessions. Previous close price was $1537 the AI prediction was $1592.6 and today’s closing price was $1599.21. The intraday ROI for MercadoLibre (MELI) was 4.05%.
Shares of MercadoLibre rose by a staggering 29.83% in from $1219.83 to $1,583.70 at 06:29 EST on Tuesday, after five consecutive sessions in a row of gains. NASDAQ is falling 0.07% to $14,241.02, after two sequential sessions in a row of losses.
MercadoLibre, Inc. operates online commerce platforms in Latin America.
Earnings Per Share
As for profitability, MercadoLibre has a trailing twelve months EPS of $19.65.
PE Ratio
MercadoLibre has a trailing twelve months price to earnings ratio of 80.6. Meaning, the purchaser of the share is investing $80.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 45.15%.
Volatility
MercadoLibre’s last week, last month’s, and last quarter’s current intraday variation average was 1.33%, 1.32%, and 1.62%.
MercadoLibre’s highest amplitude of average volatility was 1.33% (last week), 1.90% (last month), and 1.62% (last quarter).
More news about MercadoLibre.
2. Royal Caribbean Cruises (RCL)
Royal Caribbean Cruises has been having an accuracy rate of 93.39% over the last 10 sessions. Previous close price was $104.11 the AI prediction was $107.57 and today’s closing price was $106.43. The intraday ROI for Royal Caribbean Cruises (RCL) was 2.23%.
Shares of Royal Caribbean Cruises jumped by a staggering 25.99% in from $84.79 to $106.83 at 06:29 EST on Tuesday, after two consecutive sessions in a row of gains. NYSE is dropping 0.33% to $15,930.89, following the last session’s downward trend.
Royal Caribbean Cruises Ltd.
Earnings Per Share
As for profitability, Royal Caribbean Cruises has a trailing twelve months EPS of $3.28.
PE Ratio
Royal Caribbean Cruises has a trailing twelve months price to earnings ratio of 32.57. Meaning, the purchaser of the share is investing $32.57 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.71%.
More news about Royal Caribbean Cruises.
3. Baxter International (BAX)
Baxter International has been having an accuracy rate of 98.62% over the last 10 sessions. Previous close price was $36.02 the AI prediction was $37.05 and today’s closing price was $36.42. The intraday ROI for Baxter International (BAX) was 1.11%.
Shares of Baxter International rose by a staggering 14.51% in from $31.83 to $36.45 at 06:29 EST on Tuesday, after five successive sessions in a row of gains. NYSE is dropping 0.33% to $15,930.89, following the last session’s downward trend.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide.
Earnings Per Share
As for profitability, Baxter International has a trailing twelve months EPS of $0.46.
PE Ratio
Baxter International has a trailing twelve months price to earnings ratio of 79.24. Meaning, the purchaser of the share is investing $79.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.42%.
Sales Growth
Baxter International’s sales growth is negative 2.4% for the ongoing quarter and 0.6% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.7%, now sitting on 15.28B for the twelve trailing months.
Yearly Top and Bottom Value
Baxter International’s stock is valued at $36.45 at 06:29 EST, way below its 52-week high of $56.92 and way higher than its 52-week low of $31.01.
Volatility
Baxter International’s last week, last month’s, and last quarter’s current intraday variation average was 0.45%, 0.60%, and 1.33%.
Baxter International’s highest amplitude of average volatility was 0.45% (last week), 1.26% (last month), and 1.33% (last quarter).
More news about Baxter International.
4. Quidel (QDEL)
Quidel has been having an accuracy rate of 93.02% over the last 10 sessions. Previous close price was $69 the AI prediction was $70.55 and today’s closing price was $69.36. The intraday ROI for Quidel (QDEL) was 0.52%.
Shares of Quidel jumped by a staggering 15.04% in from $59.85 to $68.85 at 06:29 EST on Tuesday, following the last session’s downward trend. NASDAQ is dropping 0.07% to $14,241.02, after two consecutive sessions in a row of losses.
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions.
Earnings Per Share
As for profitability, Quidel has a trailing twelve months EPS of $-0.27.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.27%.
More news about Quidel.
5. Ingersoll (IR)
Ingersoll has been having an accuracy rate of 99.6% over the last 10 sessions. Previous close price was $71.15 the AI prediction was $71.05 and today’s closing price was $70.78. The intraday ROI for Ingersoll (IR) was 0.52%.
Shares of Ingersoll jumped by a staggering 18.03% in from $60.19 to $71.04 at 06:29 EST on Tuesday, after two successive sessions in a row of losses. NYSE is dropping 0.33% to $15,930.89, following the last session’s downward trend.
Ingersoll Rand Inc. provides various mission-critical air, fluid, energy, specialty vehicle, and medical technologies in the United States, Europe, the Middle East, India, Africa, and the Asia Pacific.
Earnings Per Share
As for profitability, Ingersoll has a trailing twelve months EPS of $1.84.
PE Ratio
Ingersoll has a trailing twelve months price to earnings ratio of 38.61. Meaning, the purchaser of the share is investing $38.61 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.57%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17.1%, now sitting on 6.46B for the twelve trailing months.
Volume
Today’s last reported volume for Ingersoll is 632939 which is 77.29% below its average volume of 2787590.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Ingersoll’s stock is considered to be oversold (<=20).
More news about Ingersoll.
6. IDEXX Laboratories (IDXX)
IDEXX Laboratories has been having an accuracy rate of 92.99% over the last 10 sessions. Previous close price was $477.31 the AI prediction was $490.89 and today’s closing price was $479.63. The intraday ROI for IDEXX Laboratories (IDXX) was 0.49%.
Shares of IDEXX Laboratories jumped by a staggering 21.37% in from $394.28 to $478.54 at 06:29 EST on Tuesday, following the last session’s upward trend. NASDAQ is falling 0.07% to $14,241.02, after two consecutive sessions in a row of losses.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide.
Earnings Per Share
As for profitability, IDEXX Laboratories has a trailing twelve months EPS of $9.8.
PE Ratio
IDEXX Laboratories has a trailing twelve months price to earnings ratio of 48.83. Meaning, the purchaser of the share is investing $48.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 92.79%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 2.4% and 7.8%, respectively.
Sales Growth
IDEXX Laboratories’s sales growth is 6.8% for the present quarter and 8.1% for the next.
More news about IDEXX Laboratories.
7. Medtronic (MDT)
Medtronic has been having an accuracy rate of 93.58% over the last 10 sessions. Previous close price was $78.67 the AI prediction was $80.16 and today’s closing price was $79. The intraday ROI for Medtronic (MDT) was 0.42%.
Shares of Medtronic jumped by a staggering 13.25% in from $69.75 to $78.99 at 06:29 EST on Tuesday, after four consecutive sessions in a row of gains. NYSE is falling 0.33% to $15,930.89, following the last session’s downward trend.
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
Earnings Per Share
As for profitability, Medtronic has a trailing twelve months EPS of $3.08.
PE Ratio
Medtronic has a trailing twelve months price to earnings ratio of 25.65. Meaning, the purchaser of the share is investing $25.65 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.01%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Medtronic’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for Medtronic is 2412610 which is 63.84% below its average volume of 6673470.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Sep 20, 2023, the estimated forward annual dividend rate is 2.76 and the estimated forward annual dividend yield is 3.98%.
Volatility
Medtronic’s last week, last month’s, and last quarter’s current intraday variation average was 0.23%, 0.73%, and 1.03%.
Medtronic’s highest amplitude of average volatility was 0.55% (last week), 1.23% (last month), and 1.03% (last quarter).
More news about Medtronic.
8. Smith & Nephew (SNN)
Smith & Nephew has been having an accuracy rate of 93.97% over the last 10 sessions. Previous close price was $25.82 the AI prediction was $26.07 and today’s closing price was $25.87. The intraday ROI for Smith & Nephew (SNN) was 0.19%.
Shares of Smith & Nephew rose by a staggering 16.99% in from $22.01 to $25.75 at 06:29 EST on Tuesday, after five consecutive sessions in a row of gains. NYSE is falling 0.33% to $15,930.89, following the last session’s downward trend.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally.
Earnings Per Share
As for profitability, Smith & Nephew has a trailing twelve months EPS of $0.5.
PE Ratio
Smith & Nephew has a trailing twelve months price to earnings ratio of 51.5. Meaning, the purchaser of the share is investing $51.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.1%.
Volume
Today’s last reported volume for Smith & Nephew is 152283 which is 89.72% below its average volume of 1481460.
Volatility
Smith & Nephew’s last week, last month’s, and last quarter’s current intraday variation average was 0.57%, 0.99%, and 1.10%.
Smith & Nephew’s highest amplitude of average volatility was 0.57% (last week), 1.21% (last month), and 1.10% (last quarter).
Moving Average
Smith & Nephew’s value is above its 50-day moving average of $24.92 and below its 200-day moving average of $28.55.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Oct 4, 2023, the estimated forward annual dividend rate is 0.75 and the estimated forward annual dividend yield is 3.47%.
More news about Smith & Nephew.
9. Insulet (PODD)
Insulet has been having an accuracy rate of 94.09% over the last 10 sessions. Previous close price was $187.38 the AI prediction was $191.84 and today’s closing price was $187.74. The intraday ROI for Insulet (PODD) was 0.19%.
Shares of Insulet rose by a staggering 40.22% in from $134.08 to $188.01 at 06:29 EST on Tuesday, following the last session’s downward trend. NASDAQ is sliding 0.07% to $14,241.02, after two sequential sessions in a row of losses.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
Earnings Per Share
As for profitability, Insulet has a trailing twelve months EPS of $1.73.
PE Ratio
Insulet has a trailing twelve months price to earnings ratio of 108.67. Meaning, the purchaser of the share is investing $108.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.18%.
More news about Insulet.
10. Coca-Cola (KO)
Coca-Cola has been having an accuracy rate of 97.2% over the last 10 sessions. Previous close price was $58.44 the AI prediction was $60.1 and today’s closing price was $58.46. The intraday ROI for Coca-Cola (KO) was 0.03%.
Shares of Coca-Cola jumped 3.95% in from $56.14 to $58.36 at 06:29 EST on Tuesday, following the last session’s downward trend. NYSE is falling 0.33% to $15,930.89, following the last session’s downward trend.
The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide.
Earnings Per Share
As for profitability, Coca-Cola has a trailing twelve months EPS of $2.47.
PE Ratio
Coca-Cola has a trailing twelve months price to earnings ratio of 23.63. Meaning, the purchaser of the share is investing $23.63 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 41.22%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Coca-Cola’s EBITDA is 6.17.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 2.2% and a negative 4.4%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8%, now sitting on 45.03B for the twelve trailing months.
Yearly Top and Bottom Value
Coca-Cola’s stock is valued at $58.36 at 06:29 EST, way under its 52-week high of $64.99 and way higher than its 52-week low of $51.55.
More news about Coca-Cola.
11. PennyMac (PFSI)
PennyMac has been having an accuracy rate of 93.25% over the last 10 sessions. Previous close price was $77.29 the AI prediction was $78.06 and today’s closing price was $77.26. The intraday ROI for PennyMac (PFSI) was -0.04%.
Shares of PennyMac jumped by a staggering 13.21% in from $68.45 to $77.49 at 06:29 EST on Tuesday, after two successive sessions in a row of losses. NYSE is falling 0.33% to $15,930.89, following the last session’s downward trend.
PennyMac Financial Services, Inc., through its subsidiaries, engages in the mortgage banking and investment management activities in the United States.
Earnings Per Share
As for profitability, PennyMac has a trailing twelve months EPS of $4.25.
PE Ratio
PennyMac has a trailing twelve months price to earnings ratio of 18.23. Meaning, the purchaser of the share is investing $18.23 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.21%.
Volatility
PennyMac’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.46%, a positive 0.57%, and a positive 1.56%.
PennyMac’s highest amplitude of average volatility was 0.74% (last week), 1.75% (last month), and 1.56% (last quarter).
Moving Average
PennyMac’s worth is way above its 50-day moving average of $68.33 and way higher than its 200-day moving average of $66.47.
Volume
Today’s last reported volume for PennyMac is 36938 which is 85.61% below its average volume of 256831.
More news about PennyMac.
12. Abbott Laboratories (ABT)
Abbott Laboratories has been having an accuracy rate of 98.74% over the last 10 sessions. Previous close price was $102.76 the AI prediction was $106.3 and today’s closing price was $102.71. The intraday ROI for Abbott Laboratories (ABT) was -0.05%.
Shares of Abbott Laboratories rose by a staggering 10.25% in from $92.79 to $102.30 at 06:29 EST on Tuesday, following the last session’s downward trend. NYSE is dropping 0.33% to $15,930.89, following the last session’s downward trend.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.
Earnings Per Share
As for profitability, Abbott Laboratories has a trailing twelve months EPS of $2.94.
PE Ratio
Abbott Laboratories has a trailing twelve months price to earnings ratio of 34.8. Meaning, the purchaser of the share is investing $34.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.03%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Abbott Laboratories’s EBITDA is 4.68.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Oct 11, 2023, the estimated forward annual dividend rate is 2.04 and the estimated forward annual dividend yield is 1.98%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 2.6%, now sitting on 39.96B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Abbott Laboratories’s stock is considered to be oversold (<=20).
More news about Abbott Laboratories.
13. American Express (AXP)
American Express has been having an accuracy rate of 93.2% over the last 10 sessions. Previous close price was $164.18 the AI prediction was $169.54 and today’s closing price was $164.04. The intraday ROI for American Express (AXP) was -0.09%.
Shares of American Express rose by a staggering 14.72% in from $142.75 to $163.76 at 06:29 EST on Tuesday, following the last session’s downward trend. NYSE is dropping 0.33% to $15,930.89, following the last session’s downward trend.
American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide.
Earnings Per Share
As for profitability, American Express has a trailing twelve months EPS of $10.67.
PE Ratio
American Express has a trailing twelve months price to earnings ratio of 15.35. Meaning, the purchaser of the share is investing $15.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.26%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 16.9% and 21%, respectively.
More news about American Express.
14. Verizon (VZ)
Verizon has been having an accuracy rate of 94.01% over the last 10 sessions. Previous close price was $37.39 the AI prediction was $37.81 and today’s closing price was $37.35. The intraday ROI for Verizon (VZ) was -0.11%.
Shares of Verizon jumped 7.73% in from $34.67 to $37.35 at 06:29 EST on Tuesday, following the last session’s downward trend. NYSE is dropping 0.33% to $15,930.89, following the last session’s downward trend.
Verizon Communications Inc., through its subsidiaries, provides communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide.
Earnings Per Share
As for profitability, Verizon has a trailing twelve months EPS of $4.97.
PE Ratio
Verizon has a trailing twelve months price to earnings ratio of 7.52. Meaning, the purchaser of the share is investing $7.52 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.75%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Verizon’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for Verizon is 5573930 which is 75.08% below its average volume of 22371700.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Oct 5, 2023, the estimated forward annual dividend rate is 2.66 and the estimated forward annual dividend yield is 7.34%.
Volatility
Verizon’s last week, last month’s, and last quarter’s current intraday variation average was 0.22%, 0.60%, and 1.07%.
Verizon’s highest amplitude of average volatility was 0.22% (last week), 0.80% (last month), and 1.07% (last quarter).
More news about Verizon.
15. AT&T (T)
AT&T has been having an accuracy rate of 99.55% over the last 10 sessions. Previous close price was $16.23 the AI prediction was $16.31 and today’s closing price was $16.21. The intraday ROI for AT&T (T) was -0.12%.
Shares of AT&T rose 5.69% in from $15.3 to $16.17 at 06:29 EST on Tuesday, following the last session’s downward trend. NYSE is falling 0.33% to $15,930.89, following the last session’s downward trend.
AT&T Inc. provides telecommunications and technology services worldwide.
Earnings Per Share
As for profitability, AT&T has a trailing twelve months EPS of $-1.51.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.76%.
Yearly Top and Bottom Value
AT&T’s stock is valued at $16.17 at 06:29 EST, way under its 52-week high of $21.53 and way higher than its 52-week low of $13.43.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Oct 5, 2023, the estimated forward annual dividend rate is 1.11 and the estimated forward annual dividend yield is 7.1%.
More news about AT&T.
16. Netflix (NFLX)
Netflix has been having an accuracy rate of 97.2% over the last 10 sessions. Previous close price was $479.77 the AI prediction was $494.98 and today’s closing price was $479.17. The intraday ROI for Netflix (NFLX) was -0.13%.
Shares of Netflix rose by a staggering 17.24% in from $408.87 to $479.36 at 06:29 EST on Tuesday, following the last session’s downward trend. NASDAQ is sliding 0.07% to $14,241.02, after two sequential sessions in a row of losses.
Netflix, Inc. provides entertainment services.
Earnings Per Share
As for profitability, Netflix has a trailing twelve months EPS of $10.02.
PE Ratio
Netflix has a trailing twelve months price to earnings ratio of 47.84. Meaning, the purchaser of the share is investing $47.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.23%.
More news about Netflix.
17. Ares Capital (ARCC)
Ares Capital has been having an accuracy rate of 93.36% over the last 10 sessions. Previous close price was $19.89 the AI prediction was $20.3 and today’s closing price was $19.85. The intraday ROI for Ares Capital (ARCC) was -0.2%.
Shares of Ares Capital rose 5.25% in from $18.84 to $19.83 at 06:29 EST on Tuesday, after two consecutive sessions in a row of losses. NASDAQ is sliding 0.07% to $14,241.02, after two consecutive sessions in a row of losses.
Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies.
Earnings Per Share
As for profitability, Ares Capital has a trailing twelve months EPS of $2.31.
PE Ratio
Ares Capital has a trailing twelve months price to earnings ratio of 8.58. Meaning, the purchaser of the share is investing $8.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.67%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Dec 13, 2023, the estimated forward annual dividend rate is 1.92 and the estimated forward annual dividend yield is 10.28%.
Volume
Today’s last reported volume for Ares Capital is 928320 which is 65.42% below its average volume of 2685040.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 4.8% and positive 3.5% for the next.
More news about Ares Capital.
18. Sysco Corporation (SYY)
Sysco Corporation has been having an accuracy rate of 97.79% over the last 10 sessions. Previous close price was $72.08 the AI prediction was $74.67 and today’s closing price was $71.9. The intraday ROI for Sysco Corporation (SYY) was -0.25%.
Shares of Sysco Corporation rose 9.33% in from $65.72 to $71.85 at 06:29 EST on Tuesday, following the last session’s downward trend. NYSE is sliding 0.33% to $15,930.89, following the last session’s downward trend.
Sysco Corporation, through its subsidiaries, engages in the marketing and distribution of various food and related products to the foodservice or food-away-from-home industry in the United States, Canada, the United Kingdom, France, and internationally.
Earnings Per Share
As for profitability, Sysco Corporation has a trailing twelve months EPS of $3.55.
PE Ratio
Sysco Corporation has a trailing twelve months price to earnings ratio of 20.24. Meaning, the purchaser of the share is investing $20.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 109.34%.
More news about Sysco Corporation.
19. T-Mobile (TMUS)
T-Mobile has been having an accuracy rate of 93.55% over the last 10 sessions. Previous close price was $149.25 the AI prediction was $152.51 and today’s closing price was $148.8. The intraday ROI for T-Mobile (TMUS) was -0.3%.
Shares of T-Mobile jumped 5.42% in from $140.82 to $148.45 at 06:29 EST on Tuesday, following the last session’s downward trend. NASDAQ is dropping 0.07% to $14,241.02, after two consecutive sessions in a row of losses.
T-Mobile US, Inc., together with its subsidiaries, provides mobile communications services in the United States, Puerto Rico, and the United States Virgin Islands.
Earnings Per Share
As for profitability, T-Mobile has a trailing twelve months EPS of $6.44.
PE Ratio
T-Mobile has a trailing twelve months price to earnings ratio of 23.05. Meaning, the purchaser of the share is investing $23.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.54%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
T-Mobile’s EBITDA is 3.54.
Moving Average
T-Mobile’s worth is higher than its 50-day moving average of $142.80 and higher than its 200-day moving average of $141.00.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 49.2% and 38.6%, respectively.
More news about T-Mobile.
20. Coca-Cola Consolidated (COKE)
Coca-Cola Consolidated has been having an accuracy rate of 98.76% over the last 10 sessions. Previous close price was $728.4 the AI prediction was $748.88 and today’s closing price was $725. The intraday ROI for Coca-Cola Consolidated (COKE) was -0.47%.
Shares of Coca-Cola Consolidated rose by a staggering 11.91% in from $642.73 to $719.28 at 06:29 EST on Tuesday, after two consecutive sessions in a row of losses. NASDAQ is falling 0.07% to $14,241.02, after two consecutive sessions in a row of losses.
Coca-Cola Consolidated, Inc., together with its subsidiaries, manufactures, markets, and distributes nonalcoholic beverages primarily products of The Coca-Cola Company in the United States.
Earnings Per Share
As for profitability, Coca-Cola Consolidated has a trailing twelve months EPS of $48.
PE Ratio
Coca-Cola Consolidated has a trailing twelve months price to earnings ratio of 14.99. Meaning, the purchaser of the share is investing $14.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.46%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Coca-Cola Consolidated’s EBITDA is 1.05.
More news about Coca-Cola Consolidated.
21. Teleflex (TFX)
Teleflex has been having an accuracy rate of 93.49% over the last 10 sessions. Previous close price was $219.89 the AI prediction was $226.79 and today’s closing price was $218.85. The intraday ROI for Teleflex (TFX) was -0.47%.
Shares of Teleflex jumped by a staggering 22.13% in from $180.11 to $219.97 at 06:29 EST on Tuesday, following the last session’s downward trend. NYSE is dropping 0.33% to $15,930.89, following the last session’s downward trend.
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
Earnings Per Share
As for profitability, Teleflex has a trailing twelve months EPS of $8.56.
PE Ratio
Teleflex has a trailing twelve months price to earnings ratio of 25.7. Meaning, the purchaser of the share is investing $25.7 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.85%.
Moving Average
Teleflex’s worth is way higher than its 50-day moving average of $199.03 and below its 200-day moving average of $231.52.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.7%, now sitting on 2.96B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Teleflex’s stock is considered to be oversold (<=20).
More news about Teleflex.
22. Marriott International (MAR)
Marriott International has been having an accuracy rate of 93.64% over the last 10 sessions. Previous close price was $209.01 the AI prediction was $215.56 and today’s closing price was $207.51. The intraday ROI for Marriott International (MAR) was -0.72%.
Shares of Marriott International rose 9.69% in from $189.02 to $207.34 at 06:29 EST on Tuesday, after two consecutive sessions in a row of losses. NASDAQ is sliding 0.07% to $14,241.02, after two successive sessions in a row of losses.
Marriott International, Inc. operates, franchises, and licenses hotel, residential, timeshare, and other lodging properties worldwide.
Earnings Per Share
As for profitability, Marriott International has a trailing twelve months EPS of $9.42.
PE Ratio
Marriott International has a trailing twelve months price to earnings ratio of 22.01. Meaning, the purchaser of the share is investing $22.01 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1446.77%.
More news about Marriott International.
23. Johnson & Johnson (JNJ)
Johnson & Johnson has been having an accuracy rate of 97.5% over the last 10 sessions. Previous close price was $152.4 the AI prediction was $156.36 and today’s closing price was $151.28. The intraday ROI for Johnson & Johnson (JNJ) was -0.73%.
Shares of Johnson & Johnson rose 3.41% in from $146.24 to $151.23 at 06:29 EST on Tuesday, following the last session’s downward trend. NYSE is dropping 0.33% to $15,930.89, following the last session’s downward trend.
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide.
Earnings Per Share
As for profitability, Johnson & Johnson has a trailing twelve months EPS of $5.34.
PE Ratio
Johnson & Johnson has a trailing twelve months price to earnings ratio of 28.32. Meaning, the purchaser of the share is investing $28.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.19%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.8%, now sitting on 98.66B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Johnson & Johnson’s stock is considered to be oversold (<=20).
Earnings Before Interest, Taxes, Depreciation, and Amortization
Johnson & Johnson’s EBITDA is 3.79.
Yearly Top and Bottom Value
Johnson & Johnson’s stock is valued at $151.23 at 06:29 EST, way below its 52-week high of $181.04 and higher than its 52-week low of $144.95.
More news about Johnson & Johnson.
24. Intuitive Surgical (ISRG)
Intuitive Surgical has been having an accuracy rate of 98.93% over the last 10 sessions. Previous close price was $317.36 the AI prediction was $326.72 and today’s closing price was $314.98. The intraday ROI for Intuitive Surgical (ISRG) was -0.75%.
Shares of Intuitive Surgical jumped by a staggering 21.96% in from $257.62 to $314.19 at 06:29 EST on Tuesday, following the last session’s downward trend. NASDAQ is dropping 0.07% to $14,241.02, after two consecutive sessions in a row of losses.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
Earnings Per Share
As for profitability, Intuitive Surgical has a trailing twelve months EPS of $4.26.
PE Ratio
Intuitive Surgical has a trailing twelve months price to earnings ratio of 73.75. Meaning, the purchaser of the share is investing $73.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.76%.
Sales Growth
Intuitive Surgical’s sales growth is 13.2% for the present quarter and 18.7% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 19.5% and 20.3%, respectively.
More news about Intuitive Surgical.
25. Charles River Laboratories (CRL)
Charles River Laboratories has been having an accuracy rate of 98.06% over the last 10 sessions. Previous close price was $196.24 the AI prediction was $201.6 and today’s closing price was $194.7. The intraday ROI for Charles River Laboratories (CRL) was -0.78%.
Shares of Charles River Laboratories jumped by a staggering 17.18% in from $168.31 to $197.22 at 06:29 EST on Tuesday, following the last session’s downward trend. NYSE is falling 0.33% to $15,930.89, following the last session’s downward trend.
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally.
Earnings Per Share
As for profitability, Charles River Laboratories has a trailing twelve months EPS of $9.24.
PE Ratio
Charles River Laboratories has a trailing twelve months price to earnings ratio of 21.34. Meaning, the purchaser of the share is investing $21.34 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.96%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 3.8%, now sitting on 4.22B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Charles River Laboratories’s EBITDA is 3.05.
More news about Charles River Laboratories.
26. Zoetis (ZTS)
Zoetis has been having an accuracy rate of 94.11% over the last 10 sessions. Previous close price was $180.25 the AI prediction was $184.03 and today’s closing price was $178.79. The intraday ROI for Zoetis (ZTS) was -0.81%.
Shares of Zoetis rose by a staggering 14.21% in from $157.28 to $179.63 at 06:29 EST on Tuesday, after two sequential sessions in a row of losses. NYSE is sliding 0.33% to $15,930.89, following the last session’s downward trend.
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally.
Earnings Per Share
As for profitability, Zoetis has a trailing twelve months EPS of $4.9.
PE Ratio
Zoetis has a trailing twelve months price to earnings ratio of 36.66. Meaning, the purchaser of the share is investing $36.66 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.02%.
Yearly Top and Bottom Value
Zoetis’s stock is valued at $179.63 at 06:29 EST, below its 52-week high of $194.99 and way above its 52-week low of $124.15.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Zoetis’s EBITDA is 86.85.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 14.8% and 6.9%, respectively.
More news about Zoetis.
27. Walt Disney (DIS)
Walt Disney has been having an accuracy rate of 93.51% over the last 10 sessions. Previous close price was $95.98 the AI prediction was $99.42 and today’s closing price was $95.17. The intraday ROI for Walt Disney (DIS) was -0.84%.
Shares of Walt Disney rose by a staggering 18.06% in from $80.53 to $95.07 at 06:29 EST on Tuesday, following the last session’s downward trend. NYSE is sliding 0.33% to $15,930.89, following the last session’s downward trend.
The Walt Disney Company operates as an entertainment company worldwide.
Earnings Per Share
As for profitability, Walt Disney has a trailing twelve months EPS of $1.29.
PE Ratio
Walt Disney has a trailing twelve months price to earnings ratio of 73.7. Meaning, the purchaser of the share is investing $73.7 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.06%.
Volatility
Walt Disney’s last week, last month’s, and last quarter’s current intraday variation average was 0.85%, 1.03%, and 1.23%.
Walt Disney’s highest amplitude of average volatility was 0.85% (last week), 1.59% (last month), and 1.23% (last quarter).
Moving Average
Walt Disney’s value is way above its 50-day moving average of $84.87 and above its 200-day moving average of $90.86.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.4%, now sitting on 88.9B for the twelve trailing months.
More news about Walt Disney.
28. Public Service Enterprise Group (PEG)
Public Service Enterprise Group has been having an accuracy rate of 98.31% over the last 10 sessions. Previous close price was $65.11 the AI prediction was $66.38 and today’s closing price was $64.44. The intraday ROI for Public Service Enterprise Group (PEG) was -1.03%.
Shares of Public Service Enterprise Group rose 7.28% in from $60.04 to $64.41 at 06:29 EST on Tuesday, after two successive sessions in a row of losses. NYSE is sliding 0.33% to $15,930.89, following the last session’s downward trend.
Public Service Enterprise Group Incorporated, through its subsidiaries, operates as an energy company primarily in Mid-Atlantic United States.
Earnings Per Share
As for profitability, Public Service Enterprise Group has a trailing twelve months EPS of $5.61.
PE Ratio
Public Service Enterprise Group has a trailing twelve months price to earnings ratio of 11.48. Meaning, the purchaser of the share is investing $11.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.52%.
Volume
Today’s last reported volume for Public Service Enterprise Group is 744774 which is 71.99% below its average volume of 2659330.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Sep 6, 2023, the estimated forward annual dividend rate is 2.28 and the estimated forward annual dividend yield is 3.79%.
More news about Public Service Enterprise Group.
29. Humana (HUM)
Humana has been having an accuracy rate of 92.74% over the last 10 sessions. Previous close price was $518.12 the AI prediction was $532.74 and today’s closing price was $510.71. The intraday ROI for Humana (HUM) was -1.43%.
Shares of Humana fell 0.88% in from $516.97 to $512.42 at 06:29 EST on Tuesday, following the last session’s downward trend. NYSE is sliding 0.33% to $15,930.89, following the last session’s downward trend.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States.
Earnings Per Share
As for profitability, Humana has a trailing twelve months EPS of $24.2.
PE Ratio
Humana has a trailing twelve months price to earnings ratio of 21.17. Meaning, the purchaser of the share is investing $21.17 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.04%.
More news about Humana.
